New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures.
作者信息
Buller Christopher E, Carere Ronald G
机构信息
Vancouver General Hospital, British Columbia.
出版信息
CMAJ. 2002 Jan 8;166(1):51-9.
Abstract
摘要
相似文献
1
New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures.
CMAJ. 2002 Jan 8;166(1):51-9.
2
Catheter-based revascularization strategies for acute coronary syndromes in women.
Rev Cardiovasc Med. 2001 Fall;2(4):181-9.
3
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).
Catheter Cardiovasc Interv. 2003 Nov;60(3):360-7. doi: 10.1002/ccd.10653.
4
Acute coronary syndrome: new advances and nursing strategies.
Dimens Crit Care Nurs. 2000 Sep-Oct;19(5):22-6.
5
Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting Thrombolysis In Myocardial Infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction.
Am J Cardiol. 2003 Apr 1;91(7):870-2. doi: 10.1016/s0002-9149(03)00023-7.
6
Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
EuroIntervention. 2010 Nov;6(5):590-5. doi: 10.4244/EIJV6I5A99.
7
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501.
8
Supplement on acute coronary syndromes: introduction.
Circulation. 2003 Oct 21;108(16 Suppl 1):III1-5. doi: 10.1161/01.CIR.0000086949.66085.f7.
9
Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
Am Heart J. 2005 Feb;149(2):275-83. doi: 10.1016/j.ahj.2004.05.055.
10
Percutaneous coronary interventions for acute myocardial infarction.
EuroIntervention. 2011 Feb;6(7):883-8. doi: 10.4244/EIJV6I7A150.
引用本文的文献
1
CYPHER coronary stents and risk of thrombosis.
CMAJ. 2003 Aug 5;169(3):218.
2
Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.
CMAJ. 2003 Jul 8;169(1):35-7.
3
Primary angioplasty for ST-segment elevation myocardial infarction: ready for prime time?
CMAJ. 2003 Jul 8;169(1):32-5.
本文引用的文献
1
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503.
2
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
N Engl J Med. 2001 Jun 21;344(25):1888-94. doi: 10.1056/NEJM200106213442502.
3
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501.
4
New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.
CMAJ. 2001 May 1;164(9):1309-16.
5
One-year survival following early revascularization for cardiogenic shock.
JAMA. 2001 Jan 10;285(2):190-2. doi: 10.1001/jama.285.2.190.
6
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.
Lancet. 2000 Dec 16;356(9247):2037-44. doi: 10.1016/S0140-6736(00)03400-0.
7
Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.
N Engl J Med. 2000 Aug 10;343(6):385-91. doi: 10.1056/NEJM200008103430602.
8
Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.
Lancet. 2000 Jul 1;356(9223):9-16. doi: 10.1016/s0140-6736(00)02427-2.
9
Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial.
Lancet. 2000 Jun 24;355(9222):2199-203. doi: 10.1016/s0140-6736(00)02403-x.
10
Improved clinical outcome after widespread use of coronary-artery stenting in Canada.
N Engl J Med. 1999 Dec 23;341(26):1957-65. doi: 10.1056/NEJM199912233412602.
Zotero 插件